+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Lymphoma Scientific Research Mentoring Program (LSRMP)

Lymphoma Research Foundation

LYMPHOMA RESEARCH FOUNDATION OVERVIEW: The Lymphoma Research Foundation remains dedicated to finding a cure for lymphoma through an innovative research program and by supporting the next generation of lymphoma researchers. LRF provides education for people with lymphoma, their loved ones and caregivers, including comprehensive disease guides and facts sheets, in-person conferences and online resources. The Foundation also provides continuing medical education programs designed to increase the knowledge, skills and performance of healthcare professionals. The Foundation’s support services, including the LRF Helpline, Clinical Trials Information Service, financial assistance programs and Lymphoma Support Network, provide direct support to people with lymphoma. To learn more about the Foundation, visit lymphoma.org.

LYMPHOMA SCIENTIFIC RESEARCH MENTORING PROGRAM OVERVIEW: The Lymphoma Research Foundation Lymphoma Scientific Research Mentoring Program (LSRMP) is an education and mentoring program with two tracks: the Clinical Track, for clinical fellows and junior faculty with a focus in clinical research in the field of lymphoma, including epidemiology, and the Laboratory/Translational Track, for researchers at the levels of postdoctoral fellow, clinical fellow, or junior faculty with an interest in laboratory-based research including, bench, translational and pathology research as well as statistical research.

The Foundation considers “lymphoma” to encompass all lymphoma subtypes, as well as chronic lymphocytic leukemia (CLL). The program is two years in length and offers a broad education on research and career development as well as managing career and quality of life issues. The goals of the LSRMP include:

• Provide mentoring and education to clinical fellows, postdoctoral fellows and junior faculty interested in lymphoma/CLL research. The program will emphasize training in scientific research methods and design, statistical analysis, pathology, incorporating and interpreting correlative studies into clinical trials, and grant submission and funding. The program also aims to foster mentorship and research collaboration among experts and trainees in the field.

• Assist in the development of a research project relevant to lymphoma which will set the foundation for grant development. For Clinical Track applicants, this should be a clinical trial or study that directly involves patients; Laboratory/Translational Track applicants may propose any laboratory, or translational research project that will advance current understanding of lymphoma biology, prognosis/diagnosis, or outcomes. Project design and implementation will be discussed in a small group setting consisting of experts in the field, statisticians, and other trainees in the program, where information, ideas, guidance, support and connections are shared, and where mentoring relationships can be developed.

• Provide continuing training, career development advice, and mentorship among trainees and experts in the field and to foster future participation and collaboration within the Lymphoma Research Foundation through follow-up programming and activities.

AI Based Application Success Predictor

The Lymphoma Research Foundation (LRF) is renowned for its reputation as the largest nonprofit fully devoted to lymphoma and CLL research. Its structured, career-stage–focused funding model—combined with rigorous peer review and mentorship—has consistently cultivated future leaders in the field. Here’s how:

1. Targeted Career Development Grants

LRF’s grant programs are designed to propel investigators from early stages to independence:

Postdoctoral Fellowship Grants: Award approximately $195,000 over three years for early-stage scientists (MD or PhD). These grants provide research salary and support, enabling focused, foundational lymphoma research.

Clinical Investigator Career Development Awards (CDA): Designed for advanced fellows or early junior faculty, offering salary, protected research time, and research expenses over three years. This award often represents a researcher's first significant independent funding.

Lymphoma Scientific Research Mentoring Program (LSRMP): A unique initiative combining hands-on mentoring, workshops, and networking. Participants (LRF Scholars) receive a $10,000 professional development grant and mentorship to strengthen future success.

Disease Focus Area Grants: Support mid-career researchers tackling specific lymphoma subtypes or populations—acting as bridge or competitive R01-style grants to facilitate larger funding.

2. Strong Success Rates

Between 2020–2024, the LRF averaged notable success rates across its early-career programs:

Clinical Investigator CDA: ~32% funding rate

Postdoctoral Fellowships: ~35%

LSRMP—Clinical Track: ~48%

LSRMP—Translational Track: ~61%

These figures underscore the foundation’s commitment to supporting promising researchers.

3. Proven Impact & Breakthroughs

LRF’s investments have directly led to some pivotal advances:

First human trials of adoptive immunotherapy in follicular lymphoma

Whole-genome sequencing of mantle cell lymphoma

Elucidation of RNA splicing roles in CLL

Discovery of biomarkers tied to mantle cell lymphoma drug resistance

Understanding mechanisms of ibrutinib resistance

4. Cultivating Talent & Visibility

In 2024 and 2025, LRF awarded many early-career researchers:

2024: 28 grants, $3.5M across institutions, supporting research into genetic mechanisms and novel treatments.

2025: 24 grants totaling $2.7M—including both CDA and postdoc fellowships—covering areas like CAR T-cell therapy and microenvironment studies.

These awardees receive spotlight features (“Researcher Spotlights”), enhancing recognition and opportunities for collaboration.

5. Real-World Traction: Success Story Example

Elisa Oricchio, a LRF Fellowship awardee, identified that the EphA7 tumor suppressor is frequently lost in follicular lymphoma. Her foundational discovery, supported by LRF, propelled her to prestigious institutional roles—becoming a tenured assistant professor and later securing an endowed chair in Translational Oncology at EPFL.

Summary Table: How LRF Grants Predict Career Success

Program / Grant	Stage	Predictive Value
Postdoctoral Fellowship	Early-career	Enables focused research, builds publication record
Clinical Investigator CDA	Early faculty	Launches independent clinical careers
LSRMP (Mentoring Program)	Mentorship & funding	Builds skills, network, and grant readiness
Disease Focus Area Grants	Mid-career	Catalyzes subtype-specific breakthroughs
Track Record of Impact	Across career stages	Leading to translational oncology advances

In Summary

The Lymphoma Research Foundation serves as a reliable predictor of success. Its tiered grants not only provide critical early funding but also deliver mentorship, visibility, and institutional credibility—key ingredients for launching impactful careers in lymphoma research.

Specialties

Cancer

Others

Oncology

Eligibility Requirements

1. Applicants must demonstrate a clear interest and commitment to a career in lymphoma clinical research. This commitment to a career focused on lymphoma-related research should be reflected in the applicant’s career development plan and in the letter of support provided by their mentor.

2. Applicants for this track must be one of the following, with requirements calculated per the applicant’s status as of March 1, 2026:

a. a junior faculty member with an MD or equivalent degree in their first five years holding a faculty position. Eligible titles include, but are not limited to, Instructor, Clinical Instructor, Assistant Professor and Clinical Assistant Professor.

b. a clinical fellow who is at least in their second year of one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, Pediatric Hematology/Oncology, or Hematopathology. Pathology fellows in one-year fellowship programs and applicants from other clinical sub-specialties will be considered based on the application’s description of the relevance of the research and career development plan to lymphoma, please contact researchgrants@lymphoma.org for eligibility review.

3. Applicants should not be more than five years beyond completion of their fellowship or more than thirteen years beyond completion of their MD or equivalent degree as of March 1, 2026.

4. Applicants must be affiliated with a sponsoring academic or nonprofit research institution in the U.S. or Canada for the duration of the LSRMP award. Citizenship is not required. LSRMP awards are open to applicants from the NIH or other U.S. government entities.

5. Applicants should not be participating in another competitively applied for mentorship (such as ASH’s CRTI) during the LSRMP period (March 2026 through October 2028). Applicants who will have completed other mentorship programs prior to March 2026 are welcome.

6. Selected applicants are required to attend and participate in all LSRMP programs in their entirety including the 2026 workshop, follow-up programs (Fall 2026 and 2027), and Foundation required communication, reporting, and evaluation. 7. Fluency in English.

8. Studies or proposals that are exclusively laboratory based are not appropriate for the Clinical Track, please see Laboratory/Translational track eligibility below. Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic methods, therapies, and/or outcome measurements directed to patients with lymphoma. Epidemiology projects are included in this track.

9. All applicants must have an identified primary mentor at their home institution who is willing and able to provide financial support for the project and demonstrate a commitment to completing the proposal in order to ensure feasibility of the proposal. Associate mentors, who may provide support for additional aspects of the project and be based at other institutions, are welcome but not a requirement.

10. LSRMP applications are self-initiated. The Lymphoma Research Foundation does not invite applications from selected individuals, institutions, or laboratories.

Sponsor Details

Sponsor Institute/Organizations: Lymphoma Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: Wall Street Plaza 88 Pine Street, Suite 2400 New York, NY 10005

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity